Brainsway Ltd. (BRSYF)
Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial
Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical